About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Phoenix | 121 Studies

Clinical Trials Prostate CancerPhoenix

Prostate Cancer Clinical Trials in Phoenix

Find 121 clinical trials for prostate cancer near Phoenix, Arizona. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 121 trials

Completed68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)This was an open-label, multicenter, single dose, Phase I/II study to evaluate the safety and tolerability of a single administration of 3 mega Becquerel (MBq)/kg, but not less…NCT03490032·Phoenix, Arizona and 4 others CompletedStereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesRATIONALE: Stereotactic radiation therapy can send x-rays directly to the tumor and cause less damage to normal tissue.NCT00377156·Phoenix, Arizona and 63 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

SuspendedThe Plenaxis® Experience StudyPraecis is currently conducting a 2000 patient Experience Study; this is a Phase IV commitment postmarketing safety study in the Food and Drug Administration (FDA) indicated…NCT00103623·Birmingham, Alabama and 59 others

CompletedA Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyThe purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency, respond to…NCT02952534·Birmingham, Alabama and 148 others

CompletedS1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate CancerThe purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation therapy (ADT) + TAK-700…NCT01809691·Birmingham, Alabama and 559 others

RecruitingPositron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical ProstatectomyThe aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.NCT06056830·Birmingham, Alabama and 33 others

Active not recruitingA Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsThe purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.NCT05787587·Phoenix, Arizona and 26 others

RecruitingA Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate CancerThe goal of the study is to evaluate how safe and how well the body handles GSK5458514 when administered in participants with prostate cancer.NCT06990880·Phoenix, Arizona and 19 others

CompletedA Study of Leuprolide to Treat Prostate CancerTo assess the efficacy and safety of 2 new formulations of leuprolide acetate 45 mg 6-month depot, Formulation A or Formulation B, for the treatment of patients with prostate…NCT00626431·Birmingham, Alabama and 62 others

CompletedIntrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical ProstatectomyIntrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men with Low PSA Biochemical Recurrence of Prostate Cancer Following…NCT06604442·Phoenix, Arizona and 8 others

CompletedEMBRACE1: Prostate BiorepositoryThe objective of this multi-center prospective observational clinical study is to evaluate the clinical performance of the Carisome Prostate assay as an aid in the diagnosis of…NCT01499381·Phoenix, Arizona

No longer availableRadium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesThis study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC patients diagnosed with symptomatic bone…NCT01516762·Birmingham, Alabama and 59 others

Active not recruitingA Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)The purpose of the study is to determine if the combination of niraparib with Abiraterone Acetate (AA) plus prednisone compared with AA plus prednisone in participants with…NCT04497844·Homewood, Alabama and 386 others

CompletedSafety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based ChemotherapyThis is a phase 3 study to compare the clinical benefit of MDV3100 versus placebo in patients with castration-resistant prostate cancer who have been previously treated with…NCT00974311·Birmingham, Alabama and 248 others

CompletedCASCARA: Castration Sensitive Carboplatin, Cabazitaxel and AbirateroneThis is a phase II clinical trial in patients with metastatic castration sensitive prostate cancer.NCT03934840·Phoenix, Arizona and 7 others

Active not recruitingTesting the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean StudyThis phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with…NCT05053152·Phoenix, Arizona and 244 others

CompletedInterstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other sources to damage tumor cells.NCT00063882·Phoenix, Arizona and 169 others

CompletedEvaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing ProstatectomyIn this phase II study, an investigative (not approved by the FDA) drug called GPI 1485 is being assessed to see if it can help preserve erectile function after prostatectomy.NCT00090376·Phoenix, Arizona and 24 others

CompletedMitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)To determine the time to progression produced by the combination of Novantrone (mitoxantrone) and Erbitux (cetuximab) versus Novantrone alone in metastatic AIPC patients…NCT00661492·Phoenix, Arizona and 54 others

CompletedC11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate AdenocarcinomaPositron emission tomography using carbon-11 acetate (AC-PET) may help find local or distant metastases from prostate cancer.NCT01530269·Phoenix, Arizona

PreviousPage 4 of 7Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma